Tower Research Capital (TRC)’s Forcendra Holding Limited Class A Ordinary Shares FCDH Stock Holding History

Tower Research Capital (TRC)’s Portfolio FCDH Stock Details FCDH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-68	Closed	-$3.45K	–	5646
2025 Q3	$3.45K	Buy	+68	New	+$2.35K	﹤0.01%	4504
2023 Q4	–	Sell	-36	Closed	-$21.4K	–	6190
2023 Q3	$21.4K	Buy	+36	New	+$20.4K	﹤0.01%	3313

Other funds holding FCDH

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return

Evolution Wealth Advisors Aventura, Florida $855M AUM 27.24% 1-Year Est. Return

Tower Research Capital (TRC)'s FCDH Position: Q4 2025 in Review

Tower Research Capital (TRC) sold out of Forcendra Holding Limited Class A Ordinary Shares (FCDH) in Q4 2025, closing a stake of 68 shares — an estimated $3.45K sold.

Tower Research Capital (TRC) first reported a position in FCDH in Q3 2023 and held it in 2 quarters. The position peaked at $21.4K in Q3 2023. 4 funds tracked by Wall St. Rank hold FCDH as of Q4 2025.

Tower Research Capital (TRC) reported no remaining Forcendra Holding Limited Class A Ordinary Shares position as of Q4 2025 after selling out during the quarter.
Tower Research Capital (TRC) sold 68 Forcendra Holding Limited Class A Ordinary Shares shares in Q4 2025, an estimated $3.45K.
Tower Research Capital (TRC) first reported a position in Forcendra Holding Limited Class A Ordinary Shares in Q3 2023 and held it in 2 quarters.
Tower Research Capital (TRC)'s Forcendra Holding Limited Class A Ordinary Shares position peaked at $21.4K in Q3 2023.
4 funds tracked by Wall St. Rank held Forcendra Holding Limited Class A Ordinary Shares as of Q4 2025.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2025, filed 17 Feb 2026.